For the Inventor, By the Inventor

Enter assignee name

Mannheim, Germany

Boehringer Mannheim Gmbh

USPTO Granted Patents = 1,164

CIPO Patents = 3

Trademarks = 25

Forward Citations = 41,418

Loading Chart...

Loading Chart...

1,214 inventors (with patents filed for the assignee):

Wolfgang Kampe (54 out of 54 patents)

Joachim Ziegenhorn (40 out of 40 patents)

Hans-Georg Batz (38 out of 45 patents)

4. Walter-Gunar Friebe (36 out of 55 patents)

5. Max Thiel (35 out of 36 patents)

6. Elmar Bosies (32 out of 36 patents)

7. Wolfgang Werner (31 out of 31 patents)

8. Alfred Mertens (30 out of 33 patents)

9. Walter Rittersdorf (28 out of 31 patents)

10. Wolfgang Gruber (28 out of 28 patents)

11. Kurt Stach (27 out of 27 patents)

12. Joachim Siedel (26 out of 26 patents)

13. Wolfgang Schaumann (25 out of 27 patents)

14. Gisbert Sponer (25 out of 28 patents)

15. Wolfgang Bartsch (25 out of 25 patents)

Core Competencies:

Biologically Active Substances

Chimeric Serine Proteases

Nucleic Acid Detection

Immunoassay Methods

Electrochemical Assays

Recombinant Proteins

Antibody Development

Liquid Transfer Devices

Analytical Systems

Blood Glucose Monitoring

Pharmaceutical Preparations

Gene Transfer Technologies

1,164 patents: Sort by Forward Citations

1. 6689755 - Method of stabilizing biologically active substances (2004-02-10),

2. 6660492 - Chimeric serine proteases (2003-12-09),

3. 6573374 - Nucleotides labelled with an infrared dye and their use in nucleic acid detection (2003-06-03),

4. 6330063 - Low coherence interferometer apparatus (2001-12-11),

5. 6274325 - Method for carrying out a homogeneous-immunoassay based on agglutination (2001-08-14),

6. 6238664 - Process for stabilizing proteins (2001-05-29),

7. 6235279 - Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins (2001-05-22),

8. 6184042 - Method for reducing hook effect in an immunoassay (2001-02-06),

9. 6180948 - Image recording system for evaluating analytical test elements (2001-01-30),

10. 6171842 - Chimeric serine proteases (2001-01-09),

11. 6159722 - Chimeric serine proteases (2000-12-12),

12. 6153192 - Peptides with a characteristic antigenic determinant of (2000-11-28),

13. 6148666 - Method and device for liquid transfer with an analysis apparatus (2000-11-21),

14. 6147199 - 2-deoxy-isoguanosines isoteric analogues and isoguanosine containing (2000-11-14),

15. 6144449 - Low coherence interferometric device (2000-11-07),

Boehringer Mannheim GmbH, headquartered in Mannheim, Germany, is a leader in biotechnology innovations, focusing on the development and manufacturing of biologically active substances. The company specializes in advanced technologies such as chimeric serine proteases, nucleic acid detection, and immunoassay methods. Its expertise extends to electrochemical assays, recombinant proteins, and antibody development, positioning it at the forefront of biotechnological advancements. Boehringer Mannheim is committed to enhancing diagnostic and therapeutic solutions through innovative liquid transfer devices and other cutting-edge applications.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Boehringer Mannheim Gmbh

1,164 Patents

#1 in G-6800 Mannheim

#42 in Germany

#885 in the World

Mannheim, Germany

Boehringer Mannheim Gmbh

Forward Citations = 41,418

1,214 inventors:

Wolfgang Kampe (54 out of 54 patents)

Joachim Ziegenhorn (40 out of 40 patents)

Hans-Georg Batz (38 out of 45 patents)

4. Walter-Gunar Friebe (36 out of 55 patents)

5. Max Thiel (35 out of 36 patents)

Please report any incorrect information to [email protected]

Loading…